![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Oxford researchers launch HIV vaccine trial
The University of Oxford has launched a Phase I trial of a novel mosaic vaccine...
Roche & Mimetas collaborate to develop human disease models for drug development
Roche is teaming up with Mimetas, a provider of organ-on-chip-based disease model to develop human...
BioMed X and Merck KGaA, Darmstadt, Germany launch new research program in oncology
BioMed X, a leading independent research institute, announced the start of its eighth joint research...
Recipharm signs Memorandum of Understanding (MOU) for the fill finish of vaccines and biotherapeutics...
Global contract development and manufacturing organisation (CDMO), Recipharm, has signed an MOU, along with His...
GSK and Alector to develop antibodies for neurodegenerative diseases
GlaxoSmithKline plc and Alector announced a strategic global collaboration for the development and commercialisation of...
Pharma Majors Collaborate for Clinical Trial of Investigational Oral Anti-Viral Drug Molnupiravir for COVID-19
Cipla Limited, Dr. Reddy’s Laboratories Ltd., Emcure Pharmaceuticals Limited, Sun Pharmaceutical Industries Limited, and Torrent...
Sanofi launches dedicated vaccines mRNA Center of Excellence
Sanofi will invest approximately €400 million annually in a first-of-its kind vaccines mRNA Center of...
Roches Actemra/RoActemra receives U.S. FDA EUA for the treatment of COVID-19 in hospitalised adults...
Roche announced that the U.S. FDA has issued an EUA for intravenous Actemra/RoActemra® (tocilizumab) for...
Fujitsu Japan Embarks on Joint Research for COVID-19 Therapies Using Fugaku
Fujitsu Japan Limited announced that it will initiate a new research project with a research...
Coriolis Pharma Expands ATMP Development Facilities
Coriolis Pharma, a provider of research and development of for (bio)pharmaceutical drugs, is expanding its...